Published online September 10, 2007
doi:10.1083/jcb.200701148
The Journal of Cell Biology, Vol. 178, No. 6, 1053-1064
The Rockefeller University Press, 0021-9525 $30.00
© 2007 Gil-Henn et al.
Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2–/– mice
Hava Gil-Henn1,
Olivier Destaing2,
Natalie A. Sims2,
Kazuhiro Aoki2,3,
Neil Alles3,
Lynn Neff2,
Archana Sanjay2,
Angela Bruzzaniti2,
Pietro De Camilli2,
Roland Baron2, and
Joseph Schlessinger1
1 Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06511
2 Departments of Cell Biology and Orthopaedics, Yale University School of Medicine, New Haven, CT 06511
3 Department of Hard Tissue Engineering, Section of Pharmacology, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8549, Japan
Correspondence to Joseph Schlessinger: joseph.schlessinger{at}yale.edu; or Roland Baron: roland.baron{at}yale.edu.
The protein tyrosine kinase Pyk2 is highly expressed in osteoclasts, where it is primarily localized in podosomes. Deletion of Pyk2 in mice leads to mild osteopetrosis due to impairment in osteoclast function. Pyk2-null osteoclasts were unable to transform podosome clusters into a podosome belt at the cell periphery; instead of a sealing zone only small actin rings were formed, resulting in impaired bone resorption. Furthermore, in Pyk2-null osteoclasts, Rho activity was enhanced while microtubule acetylation and stability were significantly reduced. Rescue experiments by ectopic expression of wild-type or a variety of Pyk2 mutants in osteoclasts from Pyk2–/– mice have shown that the FAT domain of Pyk2 is essential for podosome belt and sealing zone formation as well as for bone resorption. These experiments underscore an important role of Pyk2 in microtubule-dependent podosome organization, bone resorption, and other osteoclast functions.
H. Gil-Henn and O. Destaing contributed equally to this paper.
N.A. Sims' present address is St. Vincent's Institute, Fitzroy VIC 3065, Victoria, Australia.
K. Aoki's present address is Department of Hard Tissue Engineering, Section of Pharmacology, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8549, Japan.
A. Sanjay's present address is Department of Anatomy and Cell Biology, Temple University School of Medicine, Philadelphia, PA 19140.
Abbreviations used in this paper: FAT, focal adhesion targeting; RBD, Rho binding domain.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Related Article
-
Pyk2 for perfect bones
- Nicole LeBrasseur
J. Cell Biol. 2007 178: 891.
[Full Text]
[PDF]
This article has been cited by other articles:
-
Bruzzaniti, A., Neff, L., Sandoval, A., Du, L., Horne, W. C., Baron, R.
(2009). Dynamin Reduces Pyk2 Y402 Phosphorylation and Src Binding in Osteoclasts. Mol. Cell. Biol.
29: 3644-3656
[Abstract]
[Full Text]
-
Hazama, R., Qu, X., Yokoyama, K., Tanaka, C., Kinoshita, E., He, J., Takahashi, S., Tohyama, K., Yamamura, H., Tohyama, Y.
(2009). ATP-induced osteoclast function: the formation of sealing-zone like structure and the secretion of lytic granules via microtubule-deacetylation under the control of Syk. GENES CELLS
14: 871-884
[Abstract]
[Full Text]
-
Han, S., Mistry, A., Chang, J. S., Cunningham, D., Griffor, M., Bonnette, P. C., Wang, H., Chrunyk, B. A., Aspnes, G. E., Walker, D. P., Brosius, A. D., Buckbinder, L.
(2009). Structural Characterization of Proline-rich Tyrosine Kinase 2 (PYK2) Reveals a Unique (DFG-out) Conformation and Enables Inhibitor Design. J. Biol. Chem.
284: 13193-13201
[Abstract]
[Full Text]
-
Turner, C. H., Warden, S. J., Bellido, T., Plotkin, L. I., Kumar, N., Jasiuk, I., Danzig, J., Robling, A. G.
(2009). Mechanobiology of the Skeleton. Sci Signal
2: pt3-pt3
[Abstract]
[Full Text]
-
Wang, J., Taba, Y., Pang, J., Yin, G., Yan, C., Berk, B. C.
(2009). GIT1 Mediates VEGF-Induced Podosome Formation in Endothelial Cells: Critical Role for PLC{gamma}. Arterioscler. Thromb. Vasc. Bio.
29: 202-208
[Abstract]
[Full Text]
-
Chen, J., Lu, Y., Meng, S., Han, M.-H., Lin, C., Wang, X.
(2009). {alpha}- and {gamma}-Protocadherins Negatively Regulate PYK2. J. Biol. Chem.
284: 2880-2890
[Abstract]
[Full Text]
-
Schauwienold, D., Sastre, A. P., Genzel, N., Schaefer, M., Reusch, H. P.
(2008). The Transactivated Epidermal Growth Factor Receptor Recruits Pyk2 to Regulate Src Kinase Activity. J. Biol. Chem.
283: 27748-27756
[Abstract]
[Full Text]
-
Destaing, O., Sanjay, A., Itzstein, C., Horne, W. C., Toomre, D., De Camilli, P., Baron, R.
(2008). The Tyrosine Kinase Activity of c-Src Regulates Actin Dynamics and Organization of Podosomes in Osteoclasts. Mol. Biol. Cell
19: 394-404
[Abstract]
[Full Text]
-
Faccio, R.
(2007). Osteoclasts. Meeting Report from the 29th Annual Meeting of the American Society for Bone and Mineral Research: September 16-19, 2007 in Honolulu, Hawaii, USA. IBMS BoneKEy
4: 333-336
[Full Text]
-
LeBrasseur, N.
(2007). Pyk2 for perfect bones. JCB
178: 891-891
[Full Text]